Virtualni kongres: (R)EVOLUTION OF MICROBES from pharmaceutical point of view

Članek je objavil: DŠFS Objavljeno: 9 maj, 2020 Posodobljeno: 11 november, 2020

V sklopu IPSF Euro Sub Regions Project-a smo skupaj z društvom s Hrvaške (CPSA) in društvom iz Bosne in Hercegovine (SAFPUM) organizirali virtualni kongres, ki je potekal 8. maja 2020, od 9. do 16. ure.


🦠 Viruses and bacteria are two types of potentially disease-causing (pathogenic) particles. Viruses are much smaller than bacteria and can’t reproduce without the assistance of a host. Bacteria are capable of reproducing on their own. The symptoms of viral and bacterial illnesses are sometimes similar. Lab tests may help clarify whether an illness is caused by a virus, bacteria, or other infectious agents or disease process.
 
Some harmful microbes, for example, less than 1 % of bacteria, can invade our body (the host) and make us ill. Treating a patient with antibiotics forces the microbes to either adapt or die; this is known as ‘selective pressure’. Acquired bacterial resistance occurs when a bacterium that was originally sensitive to an antibiotic develops resistance. If a strain of a bacterial species acquires resistance to an antibiotic, it will survive the treatment. As the bacterial cell with acquired resistance multiplies, this resistance is passed on to its offspring. 🧫
 
🔬 That is the reason why microbes and their resistance are a serious threat to our healthcare system, and why we decided to invite professionals to give you a better overview on the topic. Speakers will provide helpful information regarding hospital infections, problems that healthcare professionals are facing because of AMR and possible ways of preventing and treating infections caused by microbes.